NL-OMON36470
Completed
Not Applicable
Immunological aspects of combined chemotherapy and immunotherapy with HPV16 E6/E7 Synthetic Long Peptide vaccination in patients with advanced cervical cancer. - Immunological aspects of combined chemo-immunotherapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cancer of the cervix
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 18
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patients should be at least 18 years of age;
- •\- Patients should be able and willing to provide informed consent;
- •\- Patients with a diagnosis of histologically confirmed cervical cancer that is clinically and/or radiologically proven advanced, recurrent or metastatic for whom no curative treatment (surgery or radiotherapy) options are available;
- •\- Patients scheduled for standard chemotherapy with Carboplatin / Paclitaxel;
Exclusion Criteria
- •For all patients (first and second cohort) the following exclusion criteria apply:
- •\- Any condition that in the opinion of the treating physician(s) is likely to jeopardise the well\-being of health status of the patient;
- •\- Another active malignancy
- •\- Positive test result for HIV
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
The influence of immunotherapy and chemotherapy accompanying endurance training on incidence and severity of cognitive deficits as well as other therapy-induced side effects and complications in oncological patients. A randomized controlled trialDIVERSEC00-C75Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissueDRKS00011390niversitäres Centrum für Tumorerkrankungen (UCT) FrankfurtKrankenhaus NordwestKlinik für Onkologie und Hämatologie2
Active, not recruiting
Not Applicable
Immunotherapy vs immuno-chemotherapy in patients with metastatic kidney carcinoma - NDEUCTR2006-003746-42-ITOSPEDALE ONCOLOGICO DI BARI210
Unknown
Phase 1
Clinical evaluation of NK211 and CDDP for cervical cancer.Advanced and/or recurrent cervical cancer.JPRN-jRCT2080221794ippon Kayaku Co., Ltd.
Not yet recruiting
Phase 3
The Effect of Immunonutrition and Chemotherapy Induced Neutropenia in Advanced Gastrointestinal Cancer Receiving Palliative Chemotherapy A Pilot Randomized Controlled TrialMalnutrition in Advanced Gastrointestinal Cancer Receiving Palliative Chemotherapyadvance gastrointestinal cancer, malnutritionTCTR20210723001Chulalongkorn university50
Active, not recruiting
Phase 1
Stereotactic Body Radiation in combination with immunotherapy-chemotherapy in patients with Metastatic Non-Small Cell Lung Cancer.Patients with both squamous and nonsquamous metastatic non-small cell lung cancer (NSCLC) wild type in EGFR, KRAS, ALK and ROS1.MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2021-002453-28-ITAZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA132